Gufic Biosciences Limited Share Price & Analysis
₹444.90+1.26%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹444.90+1.26%Open
₹443.90High
₹447.00Low
₹437.15Close
₹444.9052W High
₹454.0052W Low
₹268.00Volume
88KLot Size
1Sector
HealthcareMarket Cap
₹4K CrFace Value
₹1Small Cap
Price Chart
Candle
Range
Fundamentals
P/E
60.70Sector P/E
54.70P/B
6.24EPS
₹4.99ROE
10.10%ROCE
12.30%D/E Ratio
0.61Div Yield
0.02%Book Value
₹66.30Strengths
Concerns
- Trading near 52-week high (₹454)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
GUFICBIO · as of Mar 2026
Promoters72.51%
FII0.31%0.01pp
DII3.39%0.40pp
Public23.79%0.41pp
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 72.51% | 72.51% | 72.51% | 72.51% | 72.51% | 72.51% |
| FII | 0.47% | 0.12% | 0.23% | 0.23% | 0.30% | 0.31% |
| DII | 1.72% | 2.20% | 2.38% | 2.51% | 2.99% | 3.39% |
| Public | 25.29% | 25.17% | 24.89% | 24.75% | 24.20% | 23.79% |
Corporate Events
To consider and approve, inter alia, the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and financial year ended March 31, 2026, dividend and other business matters
Dividend28 May 2026
Dividend - Re 0.10 Per Share
Dividend21 Sept 2025
Annual General Meetingdividend - Re 0.10 Per Share
Dividend16 Sept 2024
Annual General Meeting/Dividend - Re 0.10 Per Share
Dividend20 Sept 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹231 Cr 2.5% | ₹237 Cr 5.8% | ₹224 Cr 9.3% | ₹205 Cr 1.4% | ₹208 Cr 2.0% | ₹204 Cr 0.5% | ₹203 Cr 4.1% | ₹195 Cr |
| Op. Profit | ₹33 Cr 13.2% | ₹38 Cr 15.2% | ₹33 Cr 26.9% | ₹26 Cr 23.5% | ₹34 Cr 12.8% | ₹39 Cr 8.3% | ₹36 Cr 5.9% | ₹34 Cr |
| OPM | 14.0% 12.5% | 16.0% 6.7% | 15.0% 15.4% | 13.0% 18.8% | 16.0% 15.8% | 19.0% 5.6% | 18.0% 0.0% | 18.0% |
| Net Profit | ₹12 Cr 29.4% | ₹17 Cr 30.8% | ₹13 Cr 62.5% | ₹8 Cr 57.9% | ₹19 Cr 13.6% | ₹22 Cr 4.8% | ₹21 Cr 5.0% | ₹20 Cr |
| EPS (₹) | 1.24 26.2% | 1.68 29.2% | 1.3 68.8% | 0.77 60.1% | 1.93 11.1% | 2.17 4.3% | 2.08 4.0% | 2 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| Revenue | ₹944 Cr 15.1% | ₹820 Cr 1.6% | ₹807 Cr |
| Expenses | ₹793 Cr 15.9% | ₹684 Cr 4.1% | ₹657 Cr |
| Op. Profit | ₹151 Cr 11.0% | ₹136 Cr 9.3% | ₹150 Cr |
| OPM | 16.0% 5.9% | 17.0% 10.5% | 19.0% |
| Other Income | ₹3 Cr 25.0% | ₹4 Cr | ₹0 Cr |
| Interest | ₹37 Cr 48.0% | ₹25 Cr 47.1% | ₹17 Cr |
| Depreciation | ₹31 Cr 47.6% | ₹21 Cr 23.5% | ₹17 Cr |
| PBT | ₹87 Cr 7.4% | ₹94 Cr 19.0% | ₹116 Cr |
| Tax % | 26.0% 0.0% | 26.0% 0.0% | 26.0% |
| Net Profit | ₹64 Cr 8.6% | ₹70 Cr 18.6% | ₹86 Cr |
| EPS (₹) | 6.4 7.9% | 6.95 19.1% | 8.59 |
| Div Payout | 0.0% 100.0% | 1.0% 0.0% | 1.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 |
|---|---|---|---|---|
Liabilities | ||||
| Equity Capital | ₹10 Cr 0.0% | ₹10 Cr 0.0% | ₹10 Cr 0.0% | ₹10 Cr |
| Reserves | ₹655 Cr 5.5% | ₹621 Cr 5.1% | ₹591 Cr 13.0% | ₹523 Cr |
| Borrowings | ₹405 Cr 9.8% | ₹369 Cr 9.8% | ₹336 Cr 0.9% | ₹333 Cr |
| Other Liabilities | ₹273 Cr 0.7% | ₹271 Cr 16.8% | ₹232 Cr 2.2% | ₹227 Cr |
| Total Liabilities | ₹1.3K Cr 5.6% | ₹1.3K Cr 8.7% | ₹1.2K Cr 7.0% | ₹1.1K Cr |
Assets | ||||
| Fixed Assets | ₹491 Cr 0.8% | ₹495 Cr 2.2% | ₹506 Cr 218.2% | ₹159 Cr |
| CWIP | ₹22 Cr 8.3% | ₹24 Cr 9.1% | ₹22 Cr 92.8% | ₹307 Cr |
| Investments | ₹2 Cr 0.0% | ₹2 Cr 0.0% | ₹2 Cr 0.0% | ₹2 Cr |
| Other Assets | ₹827 Cr 10.3% | ₹750 Cr 17.2% | ₹640 Cr 2.4% | ₹625 Cr |
| Total Assets | ₹1.3K Cr 5.6% | ₹1.3K Cr 8.7% | ₹1.2K Cr 7.0% | ₹1.1K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| Operating CF | — | ₹123 Cr 1857.1% | ₹-7 Cr |
| Investing CF | — | ₹-71 Cr 30.4% | ₹-102 Cr |
| Financing CF | — | ₹-37 Cr 145.1% | ₹82 Cr |
| Net Cash Flow | — | ₹15 Cr 155.6% | ₹-27 Cr |
| Free Cash Flow | — | ₹52 Cr 144.8% | ₹-116 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| Debtor Days | 115d 17.9% | 140d 6.0% | 149d |
| Inventory Days | 281d 33.2% | 211d 12.2% | 188d |
| Days Payable | 172d 11.0% | 155d 0.6% | 156d |
| Cash Conv. Cycle | 224d 13.7% | 197d 8.8% | 181d |
| Working Capital Days | 80d 14.0% | 93d 4.1% | 97d |
| ROCE | 12.0% 7.7% | 13.0% | — |
Source: Screener.in · Lower days = better efficiency
About Gufic Biosciences Limited
Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.
HealthcarePharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Gufic Biosciences Limited share price today?
Gufic Biosciences Limited (GUFICBIO) is currently trading at ₹444.9 on NSE, up 1.26% as of the last market session. Prices update daily after market close on MarketNetra.
Is Gufic Biosciences Limited available in F&O (Futures & Options)?
Yes, Gufic Biosciences Limited (GUFICBIO) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Gufic Biosciences Limited 52-week high and low?
Gufic Biosciences Limited's 52-week high is ₹454 and the 52-week low is ₹268. The current price of ₹444.9 is 2.0% below the 52W high.
What is Gufic Biosciences Limited P/E ratio?
Gufic Biosciences Limited's current P/E ratio is 60.7. This indicates the market is paying ₹60.7 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Gufic Biosciences Limited options?
Gufic Biosciences Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade GUFICBIO options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.